Nardil (phenelzine) is a monoamine oxidase inhibitor (MAOI) that has been forgotten by physicians because it was developed over five decades ago or ignored secondary to fear of drug/food interactions. This
Why not use lithium for Alzheimer’s disease prevention and treatment? Good question. Studies indicate that lithium is a viable option for preventing and slowing the progression of Alzheimer’s disease. Characteristics
Two diets reduce the risk for Alzheimer’s. Both the DASH diet–Dietary Approaches to Stop Hypertension and the Mediterranean diet improve brain health. Researchers combined the best of these diets to
Treatment resistant depression (TRD) can be defined as a lack of significant improvement after two adequate trials of two different antidepressants from two different pharmacologic classes (SSRIs, SNRIs and/or bupropion). Studies
Five or more of the following marks a Depressive Disorder: Depressed mood—feeling low, sad or, as Shakespeare wrote, feeling life is dull, stale, flat and unprofitable. Loss of pleasure in
Because depression is such a common disorder, I thought some of you might be interested in tidbits taken from the Carlat Psychiatry Report 16:6-7, July/August 2018 by Chris Aiken, MD.
Cicero told of Damocles who wished the pleasures of a king. Saracen magic placed him at the king’s table eating sumptuous food, drinking the finest wine and enjoying more pleasures
Rexulti (brexpiprazole) differs from Abilify (aripiprazole) in several ways. Both medications are D2 partial agonist. This property reduces dopamine output when dopamine concentrations are high thus reducing psychotic symptoms and
Borderline personality disorder (BPD) is a misnomer. The term “borderline” originated in the 1930s when psychiatrists thought that emotionally unstable patients dwelt on the border between neurosis and psychosis. The
On average people with Bipolar I Disorder spend three times more in a depressive episode than in a manic or hypomanic state; those with Bipolar II Disorder suffer 40 times
Trintellix (vortioxetine) formerly named Brintellix is a multimodal antidepressant recently approved by the FDA for the treatment of major depressive disorder that has a number of pharmacologic effects marked by
Copyright 2018 © All rights Reserved. Design by Seventh Street Marketing